| Literature DB >> 30561796 |
Renée T Fortner1, Elizabeth M Poole2, Nicolas A Wentzensen3, Britton Trabert3, Emily White4, Alan A Arslan5, Alpa V Patel6, V Wendy Setiawan7, Kala Visvanathan8, Elisabete Weiderpass9,10,11,12, Hans-Olov Adami13, Amanda Black3, Leslie Bernstein14, Louise A Brinton3, Julie Buring13,15, Tess V Clendenen5, Agnès Fournier16,17, Gary Fraser18, Susan M Gapstur6, Mia M Gaudet6, Graham G Giles19,20, Inger T Gram9, Patricia Hartge3, Judith Hoffman-Bolton8, Annika Idahl21, Rudolf Kaaks1, Victoria A Kirsh22, Synnove Knutsen18, Woon-Puay Koh23, James V Lacey14, I-Min Lee13,15, Eva Lundin24, Melissa A Merritt25,26, Roger L Milne19,20, N Charlotte Onland-Moret27, Ulrike Peters4, Jenny N Poynter28, Sabina Rinaldi29, Kim Robien30, Thomas Rohan31, Maria-José Sánchez32,33, Catherine Schairer3, Leo J Schouten34, Anne Tjonneland35, Mary K Townsend36, Ruth C Travis37, Antonia Trichopoulou38,39, Piet A van den Brandt34, Paolo Vineis26,40, Lynne Wilkens25, Alicja Wolk41, Hannah P Yang3, Anne Zeleniuch-Jacquotte5, Shelley S Tworoger2,13,36.
Abstract
Ovarian cancer risk factors differ by histotype; however, within subtype, there is substantial variability in outcomes. We hypothesized that risk factor profiles may influence tumor aggressiveness, defined by time between diagnosis and death, independent of histology. Among 1.3 million women from 21 prospective cohorts, 4,584 invasive epithelial ovarian cancers were identified and classified as highly aggressive (death in <1 year, n = 864), very aggressive (death in 1 to < 3 years, n = 1,390), moderately aggressive (death in 3 to < 5 years, n = 639), and less aggressive (lived 5+ years, n = 1,691). Using competing risks Cox proportional hazards regression, we assessed heterogeneity of associations by tumor aggressiveness for all cases and among serous and endometrioid/clear cell tumors. Associations between parity (phet = 0.01), family history of ovarian cancer (phet = 0.02), body mass index (BMI; phet ≤ 0.04) and smoking (phet < 0.01) and ovarian cancer risk differed by aggressiveness. A first/single pregnancy, relative to nulliparity, was inversely associated with highly aggressive disease (HR: 0.72; 95% CI [0.58-0.88]), no association was observed for subsequent pregnancies (per pregnancy, 0.97 [0.92-1.02]). In contrast, first and subsequent pregnancies were similarly associated with less aggressive disease (0.87 for both). Family history of ovarian cancer was only associated with risk of less aggressive disease (1.94 [1.47-2.55]). High BMI (≥35 vs. 20 to < 25 kg/m2 , 1.93 [1.46-2.56] and current smoking (vs. never, 1.30 [1.07-1.57]) were associated with increased risk of highly aggressive disease. Results were similar within histotypes. Ovarian cancer risk factors may be directly associated with subtypes defined by tumor aggressiveness, rather than through differential effects on histology. Studies to assess biological pathways are warranted.Entities:
Keywords: aggressiveness; ovarian cancer; prospective cohort; risk factors; subtypes
Mesh:
Year: 2019 PMID: 30561796 PMCID: PMC6488363 DOI: 10.1002/ijc.32075
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396